http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12533603

Outgoing Links

Predicate Object
contentType Case Reports|Letter
endingPage 404
issn 0960-8931
issueIdentifier 4
pageRange 403-404
publicationName Melanoma Research
startingPage 403
bibliographicCitation Gruss C, Geissler A, Schalke B, Landthaler M, Stolz W. Severe neurological disabilities after complete remission of advanced malignant melanoma following fotemustine therapy in combination with total brain irradiation. Melanoma Res. 2002 Aug;12(4):403–4. doi: 10.1097/00008390-200208000-00015. PMID: 12170192.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc1f9a5008deb6a99e25cc4e3365bd2f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f20c73e0d16171d3efd4bd77983d932
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf5507f00f18965677068be92ee2659e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03823b53d2c448f7330d332e07233f34
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69be15a61f602bdc3d0ae571931596c9
date 200208
identifier https://doi.org/10.1097/00008390-200208000-00015
https://pubmed.ncbi.nlm.nih.gov/12170192
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2214
https://portal.issn.org/resource/ISSN/0960-8931
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Severe neurological disabilities after complete remission of advanced malignant melanoma following fotemustine therapy in combination with total brain irradiation
discusses http://id.nlm.nih.gov/mesh/M0028268
http://id.nlm.nih.gov/mesh/M0153576
http://id.nlm.nih.gov/mesh/M0015421
http://id.nlm.nih.gov/mesh/M0014925
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D009607Q000009
http://id.nlm.nih.gov/mesh/D008545Q000556
http://id.nlm.nih.gov/mesh/D001932Q000556
http://id.nlm.nih.gov/mesh/D009943Q000009
http://id.nlm.nih.gov/mesh/D003704Q000209
http://id.nlm.nih.gov/mesh/D018906Q000009
http://id.nlm.nih.gov/mesh/D011882Q000009
http://id.nlm.nih.gov/mesh/D001925Q000209
http://id.nlm.nih.gov/mesh/D016371Q000009
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008545Q000532
http://id.nlm.nih.gov/mesh/D001921Q000473
http://id.nlm.nih.gov/mesh/D010166
http://id.nlm.nih.gov/mesh/D001925Q000139
http://id.nlm.nih.gov/mesh/D008545Q000150
http://id.nlm.nih.gov/mesh/D001921Q000528
http://id.nlm.nih.gov/mesh/D003704Q000139
http://id.nlm.nih.gov/mesh/D001932Q000532
http://id.nlm.nih.gov/mesh/D001921Q000187
http://id.nlm.nih.gov/mesh/D001932Q000188
http://id.nlm.nih.gov/mesh/D001284
http://id.nlm.nih.gov/mesh/D008545Q000188
http://id.nlm.nih.gov/mesh/D011788
http://id.nlm.nih.gov/mesh/D012074
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D018906Q000627
http://id.nlm.nih.gov/mesh/D009607Q000627
http://id.nlm.nih.gov/mesh/D009943Q000627
http://id.nlm.nih.gov/mesh/D001932Q000150
http://id.nlm.nih.gov/mesh/D003131
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104799
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128856490

Total number of triples: 60.